Low-intensity regimens standard-intensity induction strategies in acute myeloid leukemia

by Norbert Vey
Published 2020-03-01

Predicting outcome of patients with myelodysplastic syndromes after failure of azacitidine: validation of the North American MDS consortium scoring system

by Thomas Prebet, Pierre Fenaux, Norbert Vey
Published 2016-10-01

Multiple cytogenetics forms of KMT2A amplification and jumping translocation in a case of myelodysplastic syndrome

by Antoine Ittel, Norbert Vey, Marie‐Joëlle Mozziconacci
Published 2021-11-01

Current status of reduced intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia

by Didier Blaise, Norbert Vey, Catherine Faucher, Mohamad Mohty
Published 2007-04-01

Venetoclax Resistance in Acute Myeloid Leukemia

by Sylvain Garciaz, Marie-Anne Hospital, Yves Collette, Norbert Vey
Published 2024-03-01

Venetoclax in Acute Myeloid Leukemia: Molecular Basis, Evidences for Preclinical and Clinical Efficacy and Strategies to Target Resistance

by Sylvain Garciaz, Colombe Saillard, Yosr Hicheri, Marie-Anne Hospital, Norbert Vey
Published 2021-11-01

Outcome of patients with low-risk myelodysplasia after azacitidine treatment failure

by Thomas Prébet, Sylvain Thepot, Steven D. Gore, François Dreyfus, Pierre Fenaux, Norbert Vey
Published 2013-02-01

Risk of Hematologic Malignant Neoplasms after Postoperative Treatment of Breast Cancer

by Marie Joelle Jabagi, Anthony Goncalves, Norbert Vey, Thien Le Tri, Mahmoud Zureik, Rosemary Dray-Spira
Published 2019-09-01

Anthracycline dose intensification improves molecular response and outcome of patients treated for core binding factor acute myeloid leukemia

by Thomas Prebet, Sarah Bertoli, Jacques Delaunay, Arnaud Pigneux, Eric Delabesse, Marie Joelle Mozziconacci, Audrey Bidet, Christian Recher, Norbert Vey
Published 2014-10-01

P548: PRELIMINARY RESULTS OF A PHASE 1, FIRST-IN-HUMAN STUDY OF INA03, AN ANTI-CD71 ANTIBODY-DRUG CONJUGATE IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) ACUTE LEUKEMIAS

by Sylvain Garciaz, Pierre Bories, Leonor Lopez Almeida, Jean-Marie Boher, Coralie Belanger, Christian Recher, Olivier Hermine, Norbert Vey, Pierre Launay
Published 2023-08-01

Erythroleukemia: Classification

by Nathalie Cervera, Arnaud Guille, José Adélaïde, Marie‐Anne Hospital, Sylvain Garciaz, Marie‐Joelle Mozziconacci, Norbert Vey, Véronique Gelsi‐Boyer, Daniel Birnbaum
Published 2023-05-01

Acute erythroid leukemias have a distinct molecular hierarchy from non-erythroid acute myeloid leukemias

by Nathalie Cervera, Anne-Catherine Lhoumeau, José Adélaïde, Arnaud Guille, Anne Murati, Marie-Joëlle Mozziconacci, Norbert Vey, Daniel Birnbaum, Véronique Gelsi-Boyer
Published 2020-07-01

Adding lomustine to idarubicin and cytarabine for induction chemotherapy in older patients with acute myeloid leukemia: the BGMT 95 trial results

by Arnaud Pigneux, Virginie Perreau, Eric Jourdan, Norbert Vey, Nicole Dastugue, Françoise Huguet, Jean-Jacques Sotto, L. Rachid Salmi, Norbert Ifrah, Josy Reiffers
Published 2007-10-01

Prognostic Immune Effector Signature in Adult Acute Lymphoblastic Leukemia Patients Is Dominated by γδ T Cells

by Anne-Charlotte Le Floch, Marie-Sarah Rouvière, Nassim Salem, Amira Ben Amara, Florence Orlanducci, Norbert Vey, Laurent Gorvel, Anne-Sophie Chretien, Daniel Olive
Published 2023-06-01

316 EVICTION Study: Preliminary results in solid tumor patients with ICT01, a first-in-class, gamma9 delta2 T cell activating antibody targeting butyrophilin-3A

by Aurélien Marabelle, Martin Wermke, Aude de Gassart, Daniel Olive, Patrick Brune, Emmanuel Valentin, Paul Frohna, Christiane Jungels, Norbert Vey, Elena Garralda, Marina Iché
Published 2020-11-01

Prognostic impact of early adjunctive corticosteroid therapy in non-HIV oncology or haematology patients with Pneumocystis jirovecii pneumonia: A propensity score analysis.

by Mehdi Assal, Jérôme Lambert, Laurent Chow-Chine, Magali Bisbal, Luca Servan, Frederic Gonzalez, Jean Manuel de Guibert, Marion Faucher, Norbert Vey, Antoine Sannini, Djamel Mokart
Published 2021-01-01

Immunomodulatory Drugs Exert Anti-Leukemia Effects in Acute Myeloid Leukemia by Direct and Immunostimulatory Activities

by Aude Le Roy, Aude Le Roy, Thomas Prébet, Rémy Castellano, Armelle Goubard, Florence Riccardi, Florence Riccardi, Cyril Fauriat, Cyril Fauriat, Samuel Granjeaud, Audrey Benyamine, Céline Castanier, Florence Orlanducci, Florence Orlanducci, Amira Ben Amara, Amira Ben Amara, Frédéric Pont, Jean-Jacques Fournié, Yves Collette, Jean-Louis Mege, Norbert Vey, Norbert Vey, Daniel Olive, Daniel Olive
Published 2018-05-01

Tripartite prehabilitation of patients with acute myeloid leukaemia and high-risk myelodysplastic syndromes during intensive chemotherapy before allogeneic haematopoietic stem cell...

by Jean-Marie Boher, Norbert Vey, Colombe Saillard, Sarah Cuvelier, Charlène Villaron-Goetgheluck, Leonor Almeida-Lopez, Anne-Gaelle Le Corroller, Pauline Denis, Céline Rivieccio, Sarah Calvin, Cécile Bannier-Braticevic
Published 2024-03-01

Array comparative genomic hybridization and sequencing of 23 genes in 80 patients with myelofibrosis at chronic or acute phase

by Mandy Brecqueville, Jérôme Rey, Raynier Devillier, Arnaud Guille, Rémi Gillet, José Adélaide, Véronique Gelsi-Boyer, Christine Arnoulet, Max Chaffanet, Marie-Joelle Mozziconacci, Norbert Vey, Daniel Birnbaum, Anne Murati
Published 2014-01-01

Genomic analysis of myeloproliferative neoplasms in chronic and acute phases

by Frédéric Courtier, Nadine Carbuccia, Séverine Garnier, Arnaud Guille, José Adélaïde, Nathalie Cervera, Véronique Gelsi-Boyer, Marie-Joelle Mozziconacci, Jérôme Rey, Norbert Vey, Max Chaffanet, Daniel Birnbaum, Anne Murati
Published 2017-01-01